Momentum Indicators: RSI, MACD & Overbought/Oversold Status Currently, the Relative Strength Index (RSI) for AKTX stands at 41.765, which suggests a Neutral condition. Meanwhile, the MACD (12, 26) indicator is at -0.00691, providing a Sell signal for short-term momentum. Other oscillators like the Stochastic Oscillator at 35.621 and the Commodity Channel Index (CCI) at -58.126 further confirm a 0.0026 outlook for the stock.

Support, Resistance & Moving Averages From a structural perspective, AKTX is trading below its 60-day moving average of $0.274 and below its 200-day long-term moving average of $0.747. Key price levels to watch include the immediate resistance at $0.27 and strong support at $0.225. A break above $0.27 could signal a bull continuation, while falling below $0.225 may test the next Fibonacci floor at $0.205.

Akari Therapeutics PLC (AKTX) Support & Resistance Level

Name	S3	S2	S1	Pivot Points	R1	R2	R3
Classic	0.18	0.205	0.225	0.25	0.27	0.295	0.315
Fibonacci	0.205	0.222	0.233	0.25	0.267	0.278	0.295

Akari Therapeutics PLC (AKTX) Technical Indicators

2026-03-02

Name	Value
RSI_14	41.765
STOCHk_14_3_3	35.621
STOCHd_14_3_3	53.286
CCI_20	-58.126
AO_5_34	-0.00176
MOM_10	0.0026
MACD_12_26_9	-0.00691

Akari Therapeutics PLC (AKTX) Relative Strength Index (RSI) is 41.765, creating a Neutral signal.

Akari Therapeutics PLC (AKTX) Stochastic Oscillator is 35.621, creating a Neutral signal.

Akari Therapeutics PLC (AKTX) Stochastic RSI is 53.286, creating a Neutral signal.

Akari Therapeutics PLC (AKTX) Commodity Channel Index (CCI) is -58.126, creating a Neutral signal.

Akari Therapeutics PLC (AKTX) Awesome Oscillator is -0.00176, creating a Sell signal.

Akari Therapeutics PLC (AKTX) Momentum is 0.0026, creating a Buy signal.

Akari Therapeutics PLC (AKTX) MACD is -0.00691, creating a Sell signal.

Akari Therapeutics PLC (AKTX) Moving Average

2026-03-02

Period	Simple	Signal
MA_5	0.249	Sell
MA_10	0.245	Sell
MA_20	0.241	Sell
MA_60	0.274	Sell
MA_200	0.747	Sell
MA_250	0.844	Sell

Akari Therapeutics PLC (AKTX) 5-Day simple moving average is 0.249, while Akari Therapeutics PLC (AKTX) share price is $0.2356, making it a Sell.

Akari Therapeutics PLC (AKTX) 10-Day simple moving average is 0.245, while Akari Therapeutics PLC (AKTX) share price is $0.2356, making it a Sell.

Akari Therapeutics PLC (AKTX) 20-Day simple moving average is 0.241, while Akari Therapeutics PLC (AKTX) share price is $0.2356, making it a Sell.

Akari Therapeutics PLC (AKTX) 60-Day simple moving average is 0.274, while Akari Therapeutics PLC (AKTX) share price is $0.2356, making it a Sell.

Akari Therapeutics PLC (AKTX) 200-Day simple moving average is 0.747, while Akari Therapeutics PLC (AKTX) share price is $0.2356, making it a Sell.

Akari Therapeutics PLC (AKTX) 250-Day simple moving average is 0.844, while Akari Therapeutics PLC (AKTX) share price is $0.2356, making it a Sell.

People Also Watch

Frequently Asked Questions

What is the current technical consensus for AKTX?

The overall technical consensus for Akari Therapeutics PLC (AKTX) is currently Strong Sell. This rating is derived from a combined analysis of moving averages and oscillators, currently showing 2 buy signals and 2 sell signals.

What are the key support and resistance levels for Akari Therapeutics PLC (AKTX) today?

Based on pivot point calculations, Akari Therapeutics PLC (AKTX) has an immediate support level at 0.225 and a major resistance level at 0.27. Traders also monitor the pivot point at 0.25 to determine the intraday trend direction.

Is Akari Therapeutics PLC (AKTX) overbought or oversold based on the RSI?

The Relative Strength Index (RSI) for Akari Therapeutics PLC (AKTX) is currently 41.765. This indicates that the stock is in neutral territory (typically, a value below 30 is oversold and above 70 is overbought).

What signal is the MACD providing for Akari Therapeutics PLC (AKTX)?

Akari Therapeutics PLC (AKTX) Moving Averages Convergence Divergence (MACD) indicator is -0.00691, suggesting AKTX is Strong Sell. This indicator helps identify potential trend reversals or momentum shifts for Akari Therapeutics PLC.

How is Akari Therapeutics PLC (AKTX) performing relative to its 200-day moving average?

Akari Therapeutics PLC (AKTX) is currently trading at $0.2356, which is below its 200-day simple moving average of 0.747. Trading below the 200-day MA is often used by investors to determine the long-term bullish or bearish trend.

AKTX Technical

AKTX Technical

Technical Sentiment

Overall Consensus

Technical Analysis Consensus

Moving Average Consensus

Technical Analysis for AKTX